Nitin Jain

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Nitin Jain
Jan 8, 2025, 12:54 | Opinion
Nitin Jain: Heme Reports team is hosting a Spaces event for ASH24 updates in CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 22, 2024, 04:58 | Blog
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 19, 2024, 12:23 | Science
ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias
Three clinical trials yield strong results with undetectable measurable residual disease and overall response rates…
Dec 6, 2024, 10:38 | Blog
Nitin Jain: Unraveling Variability in TP53 Aberrant CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 5, 2024, 16:26 | Insight
Nitin Jain: Update on Pirto Ven and Obin triplet in firstline CLL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 5, 2024, 16:16 | Insight
Nitin Jain: Relapsed T-ALL remains a very challenging unmet need
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Dec 2, 2024, 19:24 | Insight
Naveen Pemmaraju: PVO combination program for frontline CLL treatment
Naveen Pemmaraju shared a post on X: '' ASH Kudos to Dr. Nitin Jain for an…
Nov 16, 2024, 20:28 | Insight
Naveen Pemmaraju: Our new report on DDX for mediastinal mass in patient with B-ALL
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 13, 2024, 10:45 | Blog
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
We’re excited to feature Dr. Nitin Jain, a distinguished leader in leukemia research and treatment,…
Oct 29, 2024, 17:30 | Blog
Nitin Jain: The Light the Night Houston for the Leukemia and Lymphoma Society
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Oct 17, 2024, 05:48 | Blog
Sanam Loghavi: A fantastic heme malignancies summit by Binaytara Foundation
Sanam Loghavi shared a post on X. “Thank you Binaytara Foundation, Nitin Jain, and Navneet…
Oct 16, 2024, 13:56 | Blog
Naveen Pemmaraju: Celebrating emerging collaborations across the MD Anderson Cancer Center
Naveen Pemmaraju shared on X: ''Celebrating emerging collaborations across the MD Anderson Cancer Center Cancer…
Oct 16, 2024, 11:41 | Insight
Highlights from the 2024 Summit on Haematological Cancers by The Binaytara Foundation
The 2024 Summit on Haematological Cancers by The Binaytara Foundation took place at the Hutton…
Oct 15, 2024, 15:58 | Blog
Multiple generations of University of Chicago Hematology/Oncology fellows at the Binaytara Foundation
University of Chicago Hematology/Oncology shared a post by Nitin Jain on X: ''We love seeing multiple…
Oct 15, 2024, 12:47 | Blog
Nitin Jain: Wonderful to meet colleagues and friends at the Binaytara Foundation meeting in Nashville
Nitin Jain made the following post on X: “Wonderful to meet colleagues and friends at…
Oct 12, 2024, 03:45 | Blog
Highlights from IICC 2024
The Indonesia International Cancer Conference (IICC) took place from October 3 to 5, 2024, at…
Oct 5, 2024, 16:41 | Blog
Nitin Jain: Honored to debate CS Pramesh on role of cutting edge research vs role of basic services
Nitin Jain posted on X: " My great honor to debate none other than Dr…
Sep 8, 2024, 06:13 | Societies
23 Posts Not To Miss From SOHO2024
The twelfth annual meeting of the Society of Hematologic Oncology (SOHO 2024) was held from…
Aug 18, 2024, 20:22 | Blog
Chenyu Lin: Important CAR T-cell debate in ALL featuring Ryan Cassaday and Nitin Jain
Chenyu Lin, Assistant Professor of Medicine at Duke University School of Medicine, shared on X:…
Aug 10, 2024, 13:10 | Blog
Rahul Banerjee: DAVAHeme Bermuda 2024
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "DAVAHeme Bermuda 2024.…
Aug 10, 2024, 12:55 | Insight
Jayastu Senapati: Utlility of baseline liver elastography in adults with B cell-ALL with liver toxicity
Jayastu Senapati shared a post on X: "Check out our paper just published in Blood…
Aug 9, 2024, 18:07 | Blog
5th Scientific Workshop - ESHMICRO2025
The European School of Haematology (ESH) shared on X: "ESHMICRO2025 will take place on Feb.…
Jul 23, 2024, 22:30 | Blog
Hagop Kantarjian: The simultaneous combination of ponatinib and blinatumomab highly effective
Hagop Kantarjian shared on X: "The simultaneous combination of ponatinib and blinatumomab highly effective: MRD-negativity rate…
Jul 14, 2024, 07:11 | Blog
Naveen Pemmaraju: Nitin Jain and Rami Komrokji kick off the US AML-ALL Focus meeting
Naveen Pemmaraju shared a post on X:   . "Superb talks by Nitin Jain on Highlights…
Jul 12, 2024, 16:59 | Insight
Naveen Pemmaraju: Two of the finest people I have ever known
Naveen Pemmaraju shared a post on X: “Just landed MD Education AML-ALL US Focus meeting…
Jul 10, 2024, 08:52 | Blog
Nitin Jain: CML response definitions
Fadi Haddad, Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center, reposted…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 22, 2024, 13:29 | Blog
Nitin Jain: Last day for Dr Alex Bataller as Leukemia fellow
Nitin Jain shared a post on X: "Last day for Dr Alex Bataller as Leukemia fellow.…
Jun 19, 2024, 23:09 | Blog
Wei Ying Jen: Very grateful to be standing on the shoulders of giants
Wei Ying Jen, Haematologist and Leukemia Doctor at MD Anderson Cancer Center, shared on X:…
Jun 17, 2024, 07:05 | Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 9, 2024, 14:56 | Societies
ESH MICRO 2025 registration is open
The European School of Haematology (ESH) shared a post on X: “ESH MICRO 2025 registration…
May 22, 2024, 01:53 | Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
May 21, 2024, 07:10 | Blog
Nitin Jain: Brief summary slide with some general concepts about assay depth
Nitin Jain, Professor of Medicine in the Department of Leukemia at The University of Texas MD…
May 17, 2024, 15:32 | Blog
Nitin Jain: Looking forward to frontline Rx for patients with CLL at EHA2024
Nitin Jain, Professor of Medicine in the Department of Leukemia at The University of Texas MD…
May 2, 2024, 09:25 | Blog
Rahul Gosain: HemeSeries with Nitin Jain
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "HemeSeries:…
Apr 25, 2024, 00:14 | Blog
Anand Patel: Make sure to sign up for Heme Reports next session!
Anand Patel, Assistant Professor of hematology and oncology at UChicago Medicine, shared a post by Heme…
Mar 29, 2024, 05:47 | Blog
Nitin Jain: Fantastic talk by Dr Hind Rafei on current status of NK cell therapy
Katy Rezvani Chief of Section of Cellular Therapy, Department of Stem Cell Transplantation and Cellular…
Mar 19, 2024, 03:44 | Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Feb 26, 2024, 19:14 | Blog
Nitin Jain: Our trial of ponatinib VEN + mini-CVD for R/R T-ALL is now open
Nitin Jain, the Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Feb 1, 2024, 22:40 | Blog
Naveen Pemmaraju: Super spectacular India trip now completed!
Naveen Pemmaraju shared on X/Twitter: “Super spectacular India trip now completed! Many new memories & all-time…
Dec 15, 2023, 06:01 | Blog
Othman Al-Sawaf: The primary analysis of the RT1 study just went online at Nature Medicine
Othman Al-Sawaf, haematologist and medical oncologist at the University Hospital Cologne, Cologne, Germany, shared a…
Dec 14, 2023, 16:06 | Blog
Nitin Jain: Wonderful to celebrate India’s CD19 CAR T approval
Nitin Jain, the Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Sep 18, 2023, 17:16 | Blog
Vivek Subbiah: Exhilarating discussions with my dear friend and amazing colleague Naveen Pemmaraju.
Vivek Subbiah, Executive Director at MDACC Cancer Network, shared on X/Twitter: “Exhilarating discussions with my…
Sep 16, 2023, 19:08 | Insight
Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared…
Aug 31, 2023, 19:04 | Insight
Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.
Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center, recently…
Aug 31, 2023, 18:52 | Insight
Nitin Jain: Excited to share preclinical data with CRLF2 bispecific antibody for CRLF2-rearranged B-ALL.
Quoting Nitin Jain, the Director of Leukemia CAR-T Program at the MD Anderson Cancer Center:…
Jul 29, 2023, 18:50 | Blog
All my appreciation for Naveen Pemmaraju for being a world leader in the field of BPDCN (yes 123 field !) and MPN - Nitin Jain
All my appreciation for Naveen Pemmaraju for being a world leader in the field of…
All: 47 Posts: 1 - 100
Special Coverage